Vγ9Vδ2 T-cell polyfunctionality is differently modulated in HAART-treated HIV patients according to CD4 T-cell count

Rita Casetti, Gabriele De Simone, Alessandra Sacchi, Alessandra Rinaldi, Domenico Viola, Chiara Agrati, Veronica Bordoni, Eleonora Cimini, Nicola Tumino, Francesca Besi, Federico Martini

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Alteration of γδ T-cell distribution and function in peripheral blood is among the earliest defects during HIV-infection. We asked whether the polyfunctional response could also be affected, and how this impairment could be associated to CD4 T-cell count. To this aim, we performed a cross-sectional study on HIV-infected individuals. In order to evaluate the polyfunctional-Vγ9Vδ2 T-cell response after phosphoantigen-stimulation, we assessed the cytokine/chemokine production and cytotoxicity by flow-cytometry in HAART-treated-HIV+ persons and healthy-donors. During HIV-infection Vγ9Vδ2-polyfunctional response quality is affected, since several Vγ9Vδ2 T-cell subsets resulted significantly lower in HIV+ patients in respect to healthy donors. Interestingly, we found a weak positive correlation between Vγ9Vδ2 T-cell-response and CD4 T-cell counts. By dividing the HIV+ patients according to CD4 T-cell count, we found that Low-CD4 patients expressed a lower number of two Vγ9Vδ2 T-cell subsets expressing MIP-1β in different combinations with other molecules (CD107a/IFNγ) in respect to High-CD4 individuals. Our results show that the Vγ9Vδ2 Tcellresponse quality in Low-CD4 patients is specifically affected, suggesting a direct link between innate Vγ9Vδ2 T-cells and CD4 T-cell count. These findings suggest that Vγ9Vδ2 T-cell quality may be indirectly influenced by HAART therapy and could be included in a new therapeutical strategy which would perform an important role in fighting HIV infection.

Original languageEnglish
Article numbere0132291
JournalPLoS One
Volume10
Issue number7
DOIs
Publication statusPublished - Jul 10 2015

Fingerprint

T-cells
Highly Active Antiretroviral Therapy
CD4 Lymphocyte Count
T-lymphocytes
HIV
T-Lymphocytes
HIV Infections
HIV infections
T-Lymphocyte Subsets
Tissue Donors
Chemokines
Flow cytometry
chemokines
Cytotoxicity
Flow Cytometry
cross-sectional studies
Cross-Sectional Studies
flow cytometry
cytotoxicity
Cytokines

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Vγ9Vδ2 T-cell polyfunctionality is differently modulated in HAART-treated HIV patients according to CD4 T-cell count. / Casetti, Rita; De Simone, Gabriele; Sacchi, Alessandra; Rinaldi, Alessandra; Viola, Domenico; Agrati, Chiara; Bordoni, Veronica; Cimini, Eleonora; Tumino, Nicola; Besi, Francesca; Martini, Federico.

In: PLoS One, Vol. 10, No. 7, e0132291, 10.07.2015.

Research output: Contribution to journalArticle

@article{88701994d27642809c0c71b5d0887a90,
title = "Vγ9Vδ2 T-cell polyfunctionality is differently modulated in HAART-treated HIV patients according to CD4 T-cell count",
abstract = "Alteration of γδ T-cell distribution and function in peripheral blood is among the earliest defects during HIV-infection. We asked whether the polyfunctional response could also be affected, and how this impairment could be associated to CD4 T-cell count. To this aim, we performed a cross-sectional study on HIV-infected individuals. In order to evaluate the polyfunctional-Vγ9Vδ2 T-cell response after phosphoantigen-stimulation, we assessed the cytokine/chemokine production and cytotoxicity by flow-cytometry in HAART-treated-HIV+ persons and healthy-donors. During HIV-infection Vγ9Vδ2-polyfunctional response quality is affected, since several Vγ9Vδ2 T-cell subsets resulted significantly lower in HIV+ patients in respect to healthy donors. Interestingly, we found a weak positive correlation between Vγ9Vδ2 T-cell-response and CD4 T-cell counts. By dividing the HIV+ patients according to CD4 T-cell count, we found that Low-CD4 patients expressed a lower number of two Vγ9Vδ2 T-cell subsets expressing MIP-1β in different combinations with other molecules (CD107a/IFNγ) in respect to High-CD4 individuals. Our results show that the Vγ9Vδ2 Tcellresponse quality in Low-CD4 patients is specifically affected, suggesting a direct link between innate Vγ9Vδ2 T-cells and CD4 T-cell count. These findings suggest that Vγ9Vδ2 T-cell quality may be indirectly influenced by HAART therapy and could be included in a new therapeutical strategy which would perform an important role in fighting HIV infection.",
author = "Rita Casetti and {De Simone}, Gabriele and Alessandra Sacchi and Alessandra Rinaldi and Domenico Viola and Chiara Agrati and Veronica Bordoni and Eleonora Cimini and Nicola Tumino and Francesca Besi and Federico Martini",
year = "2015",
month = "7",
day = "10",
doi = "10.1371/journal.pone.0132291",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - Vγ9Vδ2 T-cell polyfunctionality is differently modulated in HAART-treated HIV patients according to CD4 T-cell count

AU - Casetti, Rita

AU - De Simone, Gabriele

AU - Sacchi, Alessandra

AU - Rinaldi, Alessandra

AU - Viola, Domenico

AU - Agrati, Chiara

AU - Bordoni, Veronica

AU - Cimini, Eleonora

AU - Tumino, Nicola

AU - Besi, Francesca

AU - Martini, Federico

PY - 2015/7/10

Y1 - 2015/7/10

N2 - Alteration of γδ T-cell distribution and function in peripheral blood is among the earliest defects during HIV-infection. We asked whether the polyfunctional response could also be affected, and how this impairment could be associated to CD4 T-cell count. To this aim, we performed a cross-sectional study on HIV-infected individuals. In order to evaluate the polyfunctional-Vγ9Vδ2 T-cell response after phosphoantigen-stimulation, we assessed the cytokine/chemokine production and cytotoxicity by flow-cytometry in HAART-treated-HIV+ persons and healthy-donors. During HIV-infection Vγ9Vδ2-polyfunctional response quality is affected, since several Vγ9Vδ2 T-cell subsets resulted significantly lower in HIV+ patients in respect to healthy donors. Interestingly, we found a weak positive correlation between Vγ9Vδ2 T-cell-response and CD4 T-cell counts. By dividing the HIV+ patients according to CD4 T-cell count, we found that Low-CD4 patients expressed a lower number of two Vγ9Vδ2 T-cell subsets expressing MIP-1β in different combinations with other molecules (CD107a/IFNγ) in respect to High-CD4 individuals. Our results show that the Vγ9Vδ2 Tcellresponse quality in Low-CD4 patients is specifically affected, suggesting a direct link between innate Vγ9Vδ2 T-cells and CD4 T-cell count. These findings suggest that Vγ9Vδ2 T-cell quality may be indirectly influenced by HAART therapy and could be included in a new therapeutical strategy which would perform an important role in fighting HIV infection.

AB - Alteration of γδ T-cell distribution and function in peripheral blood is among the earliest defects during HIV-infection. We asked whether the polyfunctional response could also be affected, and how this impairment could be associated to CD4 T-cell count. To this aim, we performed a cross-sectional study on HIV-infected individuals. In order to evaluate the polyfunctional-Vγ9Vδ2 T-cell response after phosphoantigen-stimulation, we assessed the cytokine/chemokine production and cytotoxicity by flow-cytometry in HAART-treated-HIV+ persons and healthy-donors. During HIV-infection Vγ9Vδ2-polyfunctional response quality is affected, since several Vγ9Vδ2 T-cell subsets resulted significantly lower in HIV+ patients in respect to healthy donors. Interestingly, we found a weak positive correlation between Vγ9Vδ2 T-cell-response and CD4 T-cell counts. By dividing the HIV+ patients according to CD4 T-cell count, we found that Low-CD4 patients expressed a lower number of two Vγ9Vδ2 T-cell subsets expressing MIP-1β in different combinations with other molecules (CD107a/IFNγ) in respect to High-CD4 individuals. Our results show that the Vγ9Vδ2 Tcellresponse quality in Low-CD4 patients is specifically affected, suggesting a direct link between innate Vγ9Vδ2 T-cells and CD4 T-cell count. These findings suggest that Vγ9Vδ2 T-cell quality may be indirectly influenced by HAART therapy and could be included in a new therapeutical strategy which would perform an important role in fighting HIV infection.

UR - http://www.scopus.com/inward/record.url?scp=84941309555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941309555&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0132291

DO - 10.1371/journal.pone.0132291

M3 - Article

AN - SCOPUS:84941309555

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e0132291

ER -